Abstract:Objective To observe the effect of naftopidil tablets in the treatment of chronic prostatitis and to study the mechanism in the treatment. Methods 136 patients with chronic prostatitis were randomly divided into two groups evenly: the treatment group treated with naftopidil tablets (25 mg, qn) and levofloxacin (0.2 g, bid) and the control group treated only with levofloxacin (0.2 g, bid) for 6 weeks. Prostatic secretion examination (EPS), chronic prostatitis symptom index (CPSI), average flow rate(AFR), maximum flow rate (MFR), maximum urethral closure pressure(MUCP), maximum urethral pressure (MUP) and residual urine (RU) were compared. Results The differences between the two groups were significant in EPS, CPSI, AFR, MFR, MUCP, MUP and RU (P0.05). Conclusion Naftopidil tablets can lower the intraurethral pressure, reduce intraprostatic urinary reflux and improve the symptoms of chronic prostatitis, especially for those with the symptoms of functional urinary tract obstruction.

Treatment of 68 Cases of Chronic Prostatitis with Naftopidil